This report contains market size and forecasts of Acute Intermittent Porphyria in Global, including the following market information:
Global Acute Intermittent Porphyria Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Acute Intermittent Porphyria market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Acute Intermittent Porphyria companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Intermittent Porphyria Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Acute Intermittent Porphyria Market Segment Percentages, By Type, 2020 (%)
Gonadotropin-Releasing Hormone Analogues
Prophylactic Hematin Infusions
China Acute Intermittent Porphyria Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Acute Intermittent Porphyria Market Segment Percentages, By Application, 2020 (%)
Hospitals & Clinics
Research Centers
Global Acute Intermittent Porphyria Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Acute Intermittent Porphyria Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Acute Intermittent Porphyria Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Acute Intermittent Porphyria Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Dahaner
Roche
Bio-Rad Laboratories
Siemens
ARKRAY
Sysmex Corporation
ACON Laboratories
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Acute Intermittent Porphyria Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Intermittent Porphyria Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Intermittent Porphyria Overall Market Size
2.1 Global Acute Intermittent Porphyria Market Size: 2021 VS 2027
2.2 Global Acute Intermittent Porphyria Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Intermittent Porphyria Players in Global Market
3.2 Top Global Acute Intermittent Porphyria Companies Ranked by Revenue
3.3 Global Acute Intermittent Porphyria Revenue by Companies
3.4 Top 3 and Top 5 Acute Intermittent Porphyria Companies in Global Market, by Revenue in 2020
3.5 Global Companies Acute Intermittent Porphyria Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Intermittent Porphyria Players in Global Market
3.6.1 List of Global Tier 1 Acute Intermittent Porphyria Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Intermittent Porphyria Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Intermittent Porphyria Market Size Markets, 2021 & 2027
4.1.2 Gonadotropin-Releasing Hormone Analogues
4.1.3 Prophylactic Hematin Infusions
4.2 By Type - Global Acute Intermittent Porphyria Revenue & Forecasts
4.2.1 By Type - Global Acute Intermittent Porphyria Revenue, 2016-2021
4.2.2 By Type - Global Acute Intermittent Porphyria Revenue, 2022-2027
4.2.3 By Type - Global Acute Intermittent Porphyria Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Intermittent Porphyria Market Size, 2021 & 2027
5.1.2 Hospitals & Clinics
5.1.3 Research Centers
5.2 By Application - Global Acute Intermittent Porphyria Revenue & Forecasts
5.2.1 By Application - Global Acute Intermittent Porphyria Revenue, 2016-2021
5.2.2 By Application - Global Acute Intermittent Porphyria Revenue, 2022-2027
5.2.3 By Application - Global Acute Intermittent Porphyria Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Acute Intermittent Porphyria Market Size, 2021 & 2027
6.2 By Region - Global Acute Intermittent Porphyria Revenue & Forecasts
6.2.1 By Region - Global Acute Intermittent Porphyria Revenue, 2016-2021
6.2.2 By Region - Global Acute Intermittent Porphyria Revenue, 2022-2027
6.2.3 By Region - Global Acute Intermittent Porphyria Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Acute Intermittent Porphyria Revenue, 2016-2027
6.3.2 US Acute Intermittent Porphyria Market Size, 2016-2027
6.3.3 Canada Acute Intermittent Porphyria Market Size, 2016-2027
6.3.4 Mexico Acute Intermittent Porphyria Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Acute Intermittent Porphyria Revenue, 2016-2027
6.4.2 Germany Acute Intermittent Porphyria Market Size, 2016-2027
6.4.3 France Acute Intermittent Porphyria Market Size, 2016-2027
6.4.4 U.K. Acute Intermittent Porphyria Market Size, 2016-2027
6.4.5 Italy Acute Intermittent Porphyria Market Size, 2016-2027
6.4.6 Russia Acute Intermittent Porphyria Market Size, 2016-2027
6.4.7 Nordic Countries Acute Intermittent Porphyria Market Size, 2016-2027
6.4.8 Benelux Acute Intermittent Porphyria Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Acute Intermittent Porphyria Revenue, 2016-2027
6.5.2 China Acute Intermittent Porphyria Market Size, 2016-2027
6.5.3 Japan Acute Intermittent Porphyria Market Size, 2016-2027
6.5.4 South Korea Acute Intermittent Porphyria Market Size, 2016-2027
6.5.5 Southeast Asia Acute Intermittent Porphyria Market Size, 2016-2027
6.5.6 India Acute Intermittent Porphyria Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Acute Intermittent Porphyria Revenue, 2016-2027
6.6.2 Brazil Acute Intermittent Porphyria Market Size, 2016-2027
6.6.3 Argentina Acute Intermittent Porphyria Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Intermittent Porphyria Revenue, 2016-2027
6.7.2 Turkey Acute Intermittent Porphyria Market Size, 2016-2027
6.7.3 Israel Acute Intermittent Porphyria Market Size, 2016-2027
6.7.4 Saudi Arabia Acute Intermittent Porphyria Market Size, 2016-2027
6.7.5 UAE Acute Intermittent Porphyria Market Size, 2016-2027
7 Players Profiles
7.1 Dahaner
7.1.1 Dahaner Corporate Summary
7.1.2 Dahaner Business Overview
7.1.3 Dahaner Acute Intermittent Porphyria Major Product Offerings
7.1.4 Dahaner Acute Intermittent Porphyria Revenue in Global (2016-2021)
7.1.5 Dahaner Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Acute Intermittent Porphyria Major Product Offerings
7.2.4 Roche Acute Intermittent Porphyria Revenue in Global (2016-2021)
7.2.5 Roche Key News
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Corporate Summary
7.3.2 Bio-Rad Laboratories Business Overview
7.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Major Product Offerings
7.3.4 Bio-Rad Laboratories Acute Intermittent Porphyria Revenue in Global (2016-2021)
7.3.5 Bio-Rad Laboratories Key News
7.4 Siemens
7.4.1 Siemens Corporate Summary
7.4.2 Siemens Business Overview
7.4.3 Siemens Acute Intermittent Porphyria Major Product Offerings
7.4.4 Siemens Acute Intermittent Porphyria Revenue in Global (2016-2021)
7.4.5 Siemens Key News
7.5 ARKRAY
7.5.1 ARKRAY Corporate Summary
7.5.2 ARKRAY Business Overview
7.5.3 ARKRAY Acute Intermittent Porphyria Major Product Offerings
7.5.4 ARKRAY Acute Intermittent Porphyria Revenue in Global (2016-2021)
7.5.5 ARKRAY Key News
7.6 Sysmex Corporation
7.6.1 Sysmex Corporation Corporate Summary
7.6.2 Sysmex Corporation Business Overview
7.6.3 Sysmex Corporation Acute Intermittent Porphyria Major Product Offerings
7.6.4 Sysmex Corporation Acute Intermittent Porphyria Revenue in Global (2016-2021)
7.6.5 Sysmex Corporation Key News
7.7 ACON Laboratories
7.7.1 ACON Laboratories Corporate Summary
7.7.2 ACON Laboratories Business Overview
7.7.3 ACON Laboratories Acute Intermittent Porphyria Major Product Offerings
7.4.4 ACON Laboratories Acute Intermittent Porphyria Revenue in Global (2016-2021)
7.7.5 ACON Laboratories Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Acute Intermittent Porphyria Market Opportunities & Trends in Global Market
Table 2. Acute Intermittent Porphyria Market Drivers in Global Market
Table 3. Acute Intermittent Porphyria Market Restraints in Global Market
Table 4. Key Players of Acute Intermittent Porphyria in Global Market
Table 5. Top Acute Intermittent Porphyria Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Acute Intermittent Porphyria Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Acute Intermittent Porphyria Revenue Share by Companies, 2016-2021
Table 8. Global Companies Acute Intermittent Porphyria Product Type
Table 9. List of Global Tier 1 Acute Intermittent Porphyria Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Intermittent Porphyria Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Acute Intermittent Porphyria Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Acute Intermittent Porphyria Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Acute Intermittent Porphyria Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Acute Intermittent Porphyria Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Acute Intermittent Porphyria Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Acute Intermittent Porphyria Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Acute Intermittent Porphyria Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Acute Intermittent Porphyria Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Acute Intermittent Porphyria Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Acute Intermittent Porphyria Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Acute Intermittent Porphyria Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Acute Intermittent Porphyria Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Acute Intermittent Porphyria Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Acute Intermittent Porphyria Revenue, (US$, Mn), 2022-2027
Table 30. Dahaner Corporate Summary
Table 31. Dahaner Acute Intermittent Porphyria Product Offerings
Table 32. Dahaner Acute Intermittent Porphyria Revenue (US$, Mn), (2016-2021)
Table 33. Roche Corporate Summary
Table 34. Roche Acute Intermittent Porphyria Product Offerings
Table 35. Roche Acute Intermittent Porphyria Revenue (US$, Mn), (2016-2021)
Table 36. Bio-Rad Laboratories Corporate Summary
Table 37. Bio-Rad Laboratories Acute Intermittent Porphyria Product Offerings
Table 38. Bio-Rad Laboratories Acute Intermittent Porphyria Revenue (US$, Mn), (2016-2021)
Table 39. Siemens Corporate Summary
Table 40. Siemens Acute Intermittent Porphyria Product Offerings
Table 41. Siemens Acute Intermittent Porphyria Revenue (US$, Mn), (2016-2021)
Table 42. ARKRAY Corporate Summary
Table 43. ARKRAY Acute Intermittent Porphyria Product Offerings
Table 44. ARKRAY Acute Intermittent Porphyria Revenue (US$, Mn), (2016-2021)
Table 45. Sysmex Corporation Corporate Summary
Table 46. Sysmex Corporation Acute Intermittent Porphyria Product Offerings
Table 47. Sysmex Corporation Acute Intermittent Porphyria Revenue (US$, Mn), (2016-2021)
Table 48. ACON Laboratories Corporate Summary
Table 49. ACON Laboratories Acute Intermittent Porphyria Product Offerings
Table 50. ACON Laboratories Acute Intermittent Porphyria Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Acute Intermittent Porphyria Segment by Type
Figure 2. Acute Intermittent Porphyria Segment by Application
Figure 3. Global Acute Intermittent Porphyria Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Acute Intermittent Porphyria Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Acute Intermittent Porphyria Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Intermittent Porphyria Revenue in 2020
Figure 8. By Type - Global Acute Intermittent Porphyria Revenue Market Share, 2016-2027
Figure 9. By Application - Global Acute Intermittent Porphyria Revenue Market Share, 2016-2027
Figure 10. By Region - Global Acute Intermittent Porphyria Revenue Market Share, 2016-2027
Figure 11. By Country - North America Acute Intermittent Porphyria Revenue Market Share, 2016-2027
Figure 12. US Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Acute Intermittent Porphyria Revenue Market Share, 2016-2027
Figure 16. Germany Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 17. France Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Acute Intermittent Porphyria Revenue Market Share, 2016-2027
Figure 24. China Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 28. India Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Acute Intermittent Porphyria Revenue Market Share, 2016-2027
Figure 30. Brazil Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Acute Intermittent Porphyria Revenue Market Share, 2016-2027
Figure 33. Turkey Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Acute Intermittent Porphyria Revenue, (US$, Mn), 2016-2027
Figure 37. Dahaner Acute Intermittent Porphyria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Roche Acute Intermittent Porphyria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bio-Rad Laboratories Acute Intermittent Porphyria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Siemens Acute Intermittent Porphyria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. ARKRAY Acute Intermittent Porphyria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Sysmex Corporation Acute Intermittent Porphyria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. ACON Laboratories Acute Intermittent Porphyria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Dahaner
Roche
Bio-Rad Laboratories
Siemens
ARKRAY
Sysmex Corporation
ACON Laboratories